Physician profile
Matthew W Ryan
NPI 1487730271
$127,885.71
in general payments reported to CMS, 2019-2025
12 companies · $108K in 2025
The $108K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $151 · 2021: $3,932 · 2022: $383 · 2024: $15K · 2025: $108K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Consulting Fee: $25K · Travel and Lodging: $10K · Food and Beverage: $5,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,776.00 |
| Consulting Fee | $25,184.00 |
| Travel and Lodging | $10,342.87 |
| Food and Beverage | $5,659.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $98,805.39 | 2021-2025 | |
| Glaxosmithkline, LLC. | $24,700.50 | 2024-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $2,044.40 | 2021-2025 | Dupixent |
| Medtronic, INC. | $1,335.06 | 2021-2025 | Stealthstation S8 Platform, Propel, Fusion |
| Optinose US, INC. | $377.92 | 2019-2024 | |
| Stryker Corporation | $220.89 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $111.24 | 2025 | |
| Sanofi-Aventis U.S. LLC | $100.00 | 2020 | |
| Medtronic USA, INC. | $95.22 | 2019 | |
| Alk-Abello, INC | $34.52 | 2021 | |
| Acclarent, INC | $33.43 | 2019 | |
| Karl Storz Endoscopy-America | $27.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.